Phraxis Secures FDA Approval for EndoForce™ Connector to Revolutionize Dialysis Access
May 23, 2025
Breakthrough endovascular device advances minimally invasive arteriovenous graft creation for patients requiring hemodialysis.
Breakthrough endovascular device advances minimally invasive arteriovenous graft creation for patients requiring hemodialysis.
Breakthrough Injectable Gel Offers Minimally Invasive Relief for Patients with Degenerative Disc Disease Across Europe.
Auxilium Biotechnologies today announced enrollment of the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.
Medtronic (NYSE: MDT)+
announced today that it received CE mark for several expanded indications for its Prevail balloon catheter
AI-driven system targets real-time, lab-quality disease detection at the point of care
Medtronic (NYSE: MDT)+
this week announced it received CE Mark approval for an expanded indication of its Evolut Pro+ and Evolut FX TAVI systems, allowing the devices to be used in “redo TAVI” procedures for patients with failing transcatheter aortic valves, regardless of the original manufacturer.
Natus Medical yesterday announced that it launched BrainWatch, a point-of-care EEG solution driven by AI.
Johnson & Johnson MedTech (NYSE: JNJ)+
announced today that it launched the SoundStar Crystal ultrasound catheter.
Route 92 Medical announced today that it received FDA 510(k) clearance for its HiPoint reperfusion system.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.